“…Mycophenolate mofetil is an immunosuppressive drug mainly used in the prevention of allograft rejection in renal, cardiac or liver transplantation and in immune-mediated diseases, such as systemic lupus erythematosus, with or without renal involvement (Bomback & Appel, 2010;Mok, 2007), systemic vasculitis (Hoffman, 2010), autoimmune rheumatic diseases (Iaccarino et al, 2007) and myasthenia gravis (Hehir et al, 2010). Mycophenolate mofetil is a prodrug of mycophenolic acid that was developed to enhance its bioavailability.…”